ScoreHaematology
International Prognostic Score for advanced Hodgkin lymphoma (IPS, Hasenclever)
Counts seven adverse factors at diagnosis to estimate 5-year freedom from progression in advanced Hodgkin lymphoma.
Updated 30 October 2026
When to use it
Advanced-stage classical Hodgkin lymphoma (III–IV, or II with B symptoms or bulk depending on protocol) before starting chemotherapy.
What it needs
- Serum albumin < 4 g/dL
- Haemoglobin < 10.5 g/dL
- Male sex
- Age ≥ 45 years
- Ann Arbor stage IV
- White cells ≥ 15,000/µL
- Lymphocytes < 600/µL or < 8 % of white cells
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 0 | 5-year freedom from progression ≈ 84 % |
| 1 | 5-year freedom from progression ≈ 77 % |
| 2 | 5-year freedom from progression ≈ 67 % |
| 3 | 5-year freedom from progression ≈ 60 % |
| 4 | 5-year freedom from progression ≈ 51 % |
| ≥ 5 | 5-year freedom from progression ≈ 42 % |
Practical tip
It was derived before PET-CT and novel agents; group differences are smaller today, although it is still used to stratify trials.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
